J9070 – Cyclophosphamide, 100 mg · NDC Crosswalk & Billing Units
📋 J9070 summary
J9070 is a HCPCS Level II J-code used to bill Cyclophosphamide, 100 mg. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
💊 About Cyclophosphamide Injection DRUG GUIDE
Cyclophosphamide Injection is approved to treat a wide range of cancers in both adults and children.
These include malignant lymphomas (such as Hodgkin's disease and Burkitt's lymphoma), multiple myeloma, various leukemias, mycosis fungoides, neuroblastoma, adenocarcinoma of the ovary, retinoblastoma, and breast carcinoma.In pediatric patients only, cyclophosphamide injection is also approved to treat biopsy-proven minimal change nephrotic syndrome (a kidney condition causing protein loss in the urine) when standard steroid therapy has not worked or cannot be tolerated.
It has not been established as safe or effective for nephrotic syndrome in adults or for other kidney diseases.
🧾 Billing & reimbursement HCPCS · CMS
Full HCPCS code details (official CMS record)
🧮 Dosing & billing-units calculator HCPCS UNITS
🔁 NDCs that bill under J9070 CROSSWALKED NDCs
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|
| 81298-8114-01 | CYCLOPHOSPHAMIDE (SDV) 2 GM | Unknown | — | — | 20 | — | — | PDAC |
| 81298-8112-01 | CYCLOPHOSPHAMIDE (SDV) 1 GM | Unknown | — | — | 10 | — | — | PDAC |
| 81298-8110-01 | CYCLOPHOSPHAMIDE (SDV) 500 MG | Unknown | — | — | 5 | — | — | PDAC |
| 51407-0748-02 | CYCLOPHOSPHAMIDE 200 MG/1 ML | Unknown | — | — | 2 | — | — | PDAC |
| 51407-0749-05 | CYCLOPHOSPHAMIDE 200 MG/1 ML | Unknown | — | — | 2 | — | — | PDAC |
| 51407-0750-10 | CYCLOPHOSPHAMIDE 200 MG/1 ML | Unknown | — | — | 2 | — | — | PDAC |
| 68001-0565-28 | CYCLOPHOSPHAMIDE 200 mg/mL INJECTION, SOLUTION | BluePoint | 1 VIAL in 1 CARTON (68001-565-28) / 10 mL... | 200 mg/mL | 2 | — | ● Active | PDAC |
| 68001-0564-22 | CYCLOPHOSPHAMIDE 200 mg/mL INJECTION, SOLUTION | BluePoint | 1 VIAL in 1 CARTON (68001-564-22) / 5 mL... | 200 mg/mL | 2 | — | ● Active | PDAC |
| 50742-0521-10 | CYCLOPHOSPHAMIDE (MDV) 200 MG/1 ML | Unknown | — | — | 2 | — | — | PDAC |
| 55150-0270-01 | CYCLOPHOSPHAMIDE (SDV,PF,LATEX-FREE) 200 MG/1 ML | Unknown | — | — | 2 | — | — | PDAC |
| 55150-0271-01 | CYCLOPHOSPHAMIDE (SDV,PF,LATEX-FREE) 200 MG/1 ML | Unknown | — | — | 2 | — | — | PDAC |
| 70860-0218-05 | CYCLOPHOSPHAMIDE (MDV,PF,LATEX-FREE) 200 MG/1 ML | Unknown | — | — | 2 | — | — | PDAC |
| 70860-0218-03 | CYCLOPHOSPHAMIDE (MDV,PF,LATEX-FREE) 200 MG/1 ML | Unknown | — | — | 2 | — | — | PDAC |
| 68001-0442-26 | Cyclophosphamide 500 mg/25mL INJECTION, POWDER, FOR SOLUTION | BluePoint | 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-442... | 500 mg/25mL | 5 | — | ● Active | PDAC |
| 68001-0444-32 | Cyclophosphamide 2 g/100mL INJECTION, POWDER, FOR SOLUTION | BluePoint | 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-444... | 2 g/100mL | 20 | — | ● Active | PDAC |
| 68001-0443-27 | Cyclophosphamide 1 g/50mL INJECTION, POWDER, FOR SOLUTION | BluePoint | 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-443... | 1 g/50mL | 10 | — | ● Active | PDAC |
| 50742-0520-05 | CYCLOPHOSPHAMIDE (PF) 200 MG/1 ML | Unknown | — | — | 2 | — | — | PDAC |
| 50742-0519-02 | CYCLOPHOSPHAMIDE (PF) 200 MG/1 ML | Unknown | — | — | 2 | — | — | PDAC |
| 72603-0104-01 | CYCLOPHOSPHAMIDE (SDV,USP,PF) 500 MG | Unknown | — | — | 5 | — | — | PDAC |
| 72603-0326-01 | CYCLOPHOSPHAMIDE (SDV,USP,PF) 1 GM | Unknown | — | — | 10 | — | — | PDAC |
| 16714-0857-01 | Cyclophosphamide 1 g/50mL INJECTION, POWDER, FOR SOLUTION | NorthStar | 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-857... | 1 g/50mL | 10 | — | ● Active | PDAC |
| 16714-0859-01 | Cyclophosphamide 500 mg/25mL INJECTION, POWDER, FOR SOLUTION | NorthStar | 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-859... | 500 mg/25mL | 5 | — | ● Active | PDAC |
| 16714-0858-01 | Cyclophosphamide 2 g/100mL INJECTION, POWDER, FOR SOLUTION | NorthStar | 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-858... | 2 g/100mL | 20 | — | ● Active | PDAC |
| 68001-0372-32 | CYCLOPHOSPHAMIDE (SDV,USP,PF) 2 GM | Unknown | — | — | 20 | — | — | PDAC |
| 68001-0371-32 | CYCLOPHOSPHAMIDE (SDV,USP,PF) 1 GM | Unknown | — | — | 10 | — | — | PDAC |
| 68001-0370-27 | CYCLOPHOSPHAMIDE (SDV,USP,PF) 500 MG | Unknown | — | — | 5 | — | — | PDAC |
| 70121-1238-01 | Cyclophosphamide 500 mg/25mL INJECTION, POWDER, FOR SOLUTION | Amneal | 1 VIAL, SINGLE-DOSE in 1 CARTON (70121-123... | 500 mg/25mL | 5 | — | ● Active | PDAC |
| 70121-1239-01 | Cyclophosphamide 1 g/50mL INJECTION, POWDER, FOR SOLUTION | Amneal | 1 VIAL, SINGLE-DOSE in 1 CARTON (70121-123... | 1 g/50mL | 10 | — | ● Active | PDAC |
| 70121-1240-01 | Cyclophosphamide 2 g/100mL INJECTION, POWDER, FOR SOLUTION | Amneal | 1 VIAL, SINGLE-DOSE in 1 CARTON (70121-124... | 2 g/100mL | 20 | — | ● Active | PDAC |
🗺️ Medicare utilization & spend CMS · PART B
📊 What bills under J9070
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
🗃️ Data sources & freshness
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.